Grievence Report Form Webpage

Substance Abuse and Mental Health Services Administration
(SAMHSA)

Center for
Substance Abuse Treatment (CSAT)
Telephone (240) 276-2717

1Choke
Cherry Road, Room 2-1065
Facsimile (240) 276-1630

Rockville,
Maryland 20857
E-mail: [email protected]

Division
of Pharmacologic Therapies
DPT

C. Todd Rosendale, MA

Public Health Advisor

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ FACSIMILE

AInformation Memorandum@

 

This facsimile is intended only for the
addressee indicated below, and any review, dissemination or
use of this trans-
Mission or its contents by
persons other than the addressee
is
strictly prohibited in accordance with 42 CFR Part 2,
Confidentiality
of Alcohol and Drug Abuse Patient Records

TO: State Methadone Authorities

Opioid Treatment
Programs:

Alabama, Arkansas,
Florida,

Georgia,
Kentucky, Louisiana,

Missouri, N. Carolina, S. Carolina,

Oklahoma, Tennessee, Texas

 

FROM:C. Todd Rosendale, MA

 

RE: Emergency
Medication for Patients of Programs

Impacted
by Hurricane Katrina

 

DATE: August 31, 2005

 

 

 

The Division of Pharmacologic
Therapies is aware of the growing need to provide access to medication for the
large number of patients displaced from the programs impacted either directly
or indirectly by Hurricane Katrina, and we have the following guidance relative
to the provision of emergency medication to those persons identifying
themselves as patients of one of the affected treatment programs. Many of the patients you encounter will not
only need medication, they will also have suffered the loss of their residence
and have no assurance as to when and where they will relocate. Therefore, please include a large dose of
compassion with your usual due caution when dispensing methadone.

 

Emergency Guidance:

 

~ All necessary identification and
dosing information relative to patients of the DRD New Orleans Medical Clinic
can be ascertained by calling (800) 447-8801 and asking for Janet or Laura.

 

~ If you are unable to contact the
patients home program, the following procedures should be combined with your
existing emergency plans:

 

1)     
The emergency guest patient should show valid
picture identification which includes an address in close proximity to the
areas impacted by Hurricane Katrina.

2)     
The patient should show some type of proof that
indicates they were receiving services from a clinic located in one of the
devastated areas (medication bottle, program identification card, receipt for
payment of fees, etc.). In cases where
the patient does not have any items of proof, the program may use their best
clinical/medical judgment, possibly combined with a stat drug test for the
presence of methadone (dip stick, etc.).

3)     
The program may administer the amount of medication
that the patient reports as their current dose; however, remind each patient
that the dose they report will be verified with the home program ASAP. In cases where the reported dose appears
questionable, it is best to use good medical judgment when determining the dose
level.

4)     
Emergency guest patients should be medicated daily
with take-home doses provided only for days that the program is closed (Sundays
and holidays). In the case of a patient
who must travel an extreme distance to receive the medication, take-home
medication may be considered via the SMA-168 Request for Exception process.

5)     
The submission of an SMA-168 Request for Exception
to CSAT will not be necessary for the emergency guest patient; however, the
following information should be collected daily and submitted to CSAT when all
patients have returned to their home programs or have been permanently
relocated to another program:

a)                 
assign each patient a guest clinic identification
number and compile a temporary chart.

b)                 
attempt to contact the home program of the emergency
guest patient each day prior to administering the medication and record the
result in the temporary chart.

c)                 
record the day, date and amount of medication
administered to each patient along with any observations made by the staff
person.

 

Should there be any questions or
issues not covered in this Information
Memorandum
, please feel free to call me at (240) 276-2717.

 

The Medication Assisted Treatment community
of OTPs should be very proud. Their immediate
offers of assistance and outpouring of concern to the patients whose lives have
been impacted so drastically has been gratifying.

 

We have attached contact information
for 37 OTPs in three states to aid in contacting the home programs for displaced
patients.

 

 

 

 

Similar Posts

  • Myths About Methadone by Emmett Velten

    Admin 01/07/2022

    Education Series Number 3 March 1992 Emmett Velten, Ph.D. is the Clinical Supervisor at the BAART Methadone Program, San Francisco, California. He has worked in methadone treatment as a clinician for over 25 years. Methadone has inspired an immense mythology. Perhaps it is the most extensive mythology surrounding any form of medical or psychological treatment,…

  • Making Methadone Safe

    Admin 08/05/2022

    p3″ align=”center”>References American Association for the Treatment of Opiate Dependence. QTc Interval Screening – AATOD Policy and Guidance Statement (March 30, 2009). Available from AATOD, 225 Varick Street, New York, NY 10014. Black, L. DEA officials visit Waukegan clinic during probe of methadone death. Chicago Tribune (August 7, 2009). Omaha News Staff. Father Believes Son…

  • 3237 North Dousman Milwaukee, WI 53212

    Admin 03/10/2021

    Wisconsin Chapter of the National Alliance of Methadone Advocates 3237 North Dousman Milwaukee, WI 53212 President Greg Keller Mission Statement WI NAMA believes in the same Mission and goals as NAMA. Since its beginning over 25 years ago, methadone maintenance has been the most popular treatment for narcotic addiction. Many times over the years methadone…

  • The Pharmacology of Opioids

    Admin 04/18/2023

    Basic Pharmacology:  How Methadone Works Part 2 Basic Opioid Pharmacology All natural and synthetic opioids exhibit a three dimensional T-shaped configuration (Barchas, Berger, Ciaranello and Elliott, 1977). This T-shaped molecule has two broad hydrophobic surfaces which are at right angles and a methylated nitrogen which is usually charged at physiological pH. The charged nitrogen is…

  • NAMA Talk

    Admin 02/07/2022

    Volumn 2, Number 1 February 15, 2000 Organizational News by Joycelyn Woods The big news as this year and the Millennium closes is that methadone is slowly moving to being an accepted medical treatment. This is only the beginning THE FIRST STEP – and there is still an immense amount of work to be done….

  • The First Methadone Advocacy Conference

    Admin 04/25/2022

      Time:  September 26, 1998  9:30 AM to 5 PM Place: Roosevelt Hospital Auditorium  1000 Tenth Avenue  between 58-59th Street  New York City Topics:  A conference for methadone patients and by methadone patients. This important conference gives a voice to the voiceless. Topics discussed will be stigma, prejudice, misunderstandings about methadone, new regulations, physician prescribing…